{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:28:10Z","timestamp":1793795290712,"version":"4.6.1"},"reference-count":148,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF22OC0076184"],"award-info":[{"award-number":["NNF22OC0076184"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8162\/A29083"],"award-info":[{"award-number":["C8162\/A29083"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estimates of breast cancer overdiagnosis from randomized mammography trials range from \u223c0 to \u223c50%, reflecting methodological inconsistencies including handling of exit screening and post-screening compensatory drops. A coherent framework for interpreting trial results is needed to aid clinical counseling and guideline development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a unified reanalysis of randomized mammography trials using a reference-based approach. As reference, we used observations from the population-based service screening program in Funen, Denmark, where the temporal pattern of relative proportions (RPs) was used to describe the excess cumulative breast cancer incidence in birth cohorts invited vs not invited to screening. Trial reports identified via PubMed and prior reviews provided cumulative incidence estimates by arm and follow-up period. Control arms with exit screening were reanalyzed as screened. Observed RPs were compared with those expected under the Funen pattern at corresponding timepoints. The hypothesis was that close agreement between observed and expected RPs would indicate compatibility with low overall overdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across 52 timepoints, 73 observed RPs closely matched those expected under the Funen reference pattern for invasive cancer with and without ductal carcinoma in situ. Deviations were plausibly related to incomplete reporting in early trial phases. Most 95% confidence intervals for the observed RPs overlapped expected RP values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>When analyzed within a consistent framework accounting for exit screening and follow-up timing, mammography trials yield consistent excess-incidence patterns compatible with very low overdiagnosis (&amp;lt;5%). This supports balanced clinical and policy discussions without relying on unadjusted excess diagnoses as stand-alone overdiagnosis estimates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag302","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:40:15Z","timestamp":1788522015000},"source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer overdiagnosis in mammography trials\u2014separating signal from noise: a meta-analysis"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0429-4176","authenticated-orcid":false,"given":"Sisse Helle","family":"Njor","sequence":"first","affiliation":[{"name":"Research Unit for Screening and Epidemiology, Lillebaelt Hospital\u2014University Hospital of Southern Denmark , Vejle,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus,","place":["Denmark"]},{"name":"Department of Regional Health Services Research, Southern Denmark University , Odense,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7141-865X","authenticated-orcid":false,"given":"Casper Urth","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Research Unit for Screening and Epidemiology, Lillebaelt Hospital\u2014University Hospital of Southern Denmark , Vejle,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4785-5236","authenticated-orcid":false,"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-2238","authenticated-orcid":false,"given":"Robert A","family":"Smith","sequence":"additional","affiliation":[{"name":"Center for Early Cancer Detection, American Cancer Society , Atlanta, GA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-645X","authenticated-orcid":false,"given":"Matejka","family":"Rebolj","sequence":"additional","affiliation":[{"name":"Centre for Cancer Screening, Prevention, and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"2026110406524874000_djag302-B1","author":"UK National Screening Committee","year":"2022"},{"key":"2026110406524874000_djag302-B2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2471\/blt.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"2026110406524874000_djag302-B3","author":"Wilson"},{"key":"2026110406524874000_djag302-B4","doi-asserted-by":"publisher","first-page":"j5224","DOI":"10.1136\/bmj.j5224","article-title":"Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study","volume":"359","author":"Autier","year":"2017","journal-title":"BMJ"},{"key":"2026110406524874000_djag302-B5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ypmed.2016.06.033","article-title":"Revised estimates of overdiagnosis from the Canadian National Breast Screening Study","volume":"90","author":"Baines","year":"2016","journal-title":"Prev Med"},{"key":"2026110406524874000_djag302-B6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0969141315587344","article-title":"Informed decision-making and breast cancer screening","volume":"22","author":"Sasieni","year":"2015","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/bcr1354","article-title":"Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer","volume":"7","author":"Duffy","year":"2005","journal-title":"Breast Cancer Res"},{"key":"2026110406524874000_djag302-B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24550","article-title":"Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT","volume":"24","author":"Duffy","year":"2020","journal-title":"Health Technol Assess"},{"key":"2026110406524874000_djag302-B9","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/bcr3427","article-title":"Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time","volume":"15","author":"Duffy","year":"2013","journal-title":"Breast Cancer Res"},{"key":"2026110406524874000_djag302-B10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/s0140-6736(94)90105-8","article-title":"Extra incidence caused by mammographic screening","volume":"343","author":"Boer","year":"1994","journal-title":"Lancet"},{"key":"2026110406524874000_djag302-B11","doi-asserted-by":"publisher","first-page":"f1064","DOI":"10.1136\/bmj.f1064","article-title":"Overdiagnosis in screening mammography in Denmark: population based cohort study","volume":"346","author":"Njor","year":"2013","journal-title":"BMJ"},{"key":"2026110406524874000_djag302-B12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/epirev\/mxr009","article-title":"Interpreting overdiagnosis estimates in population-based mammography screening","volume":"33","author":"de Gelder","year":"2011","journal-title":"Epidemiol Rev"},{"key":"2026110406524874000_djag302-B13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/ijc.31420","article-title":"As you like it: how the same data can support manifold views of overdiagnosis in breast cancer screening","volume":"143","author":"Njor","year":"2018","journal-title":"Int J Cancer"},{"key":"2026110406524874000_djag302-B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0969141316631375","article-title":"Evaluation issues in the Swedish Two-County Trial of breast cancer screening: an historical review","volume":"24","author":"Tabar","year":"2017","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/tbj.12354","article-title":"Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs","volume":"21","author":"Tabar","year":"2015","journal-title":"Breast J"},{"key":"2026110406524874000_djag302-B16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1158\/1055-9965.EPI-25-0201","article-title":"Late-stage outcomes as surrogates for mortality in cancer screening trials: a systematic review and meta-analysis","volume":"34","author":"Rebolj","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026110406524874000_djag302-B17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13643-024-02700-3","article-title":"Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline","volume":"13","author":"Bennett","year":"2024","journal-title":"Syst Rev"},{"key":"2026110406524874000_djag302-B18","doi-asserted-by":"publisher","first-page":"CD001877","DOI":"10.1002\/14651858.CD001877.pub5","article-title":"Screening for breast cancer with mammography","volume":"2013","author":"G\u00f8tzsche","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026110406524874000_djag302-B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0969141320986186","article-title":"Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies","volume":"28","author":"Kopans","year":"2021","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B20","author":"Moher","year":"2017"},{"key":"2026110406524874000_djag302-B21","author":"Havrilesky","year":"2014"},{"key":"2026110406524874000_djag302-B22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1186\/s12885-017-3929-6","article-title":"Outcome of breast cancer screening in Denmark","volume":"17","author":"Lynge","year":"2017","journal-title":"BMC Cancer"},{"key":"2026110406524874000_djag302-B23","first-page":"1","article-title":"Mammography screening in the county of Fyn. November 1993-December 1999","volume":"111","author":"Njor","year":"2003","journal-title":"APMIS"},{"key":"2026110406524874000_djag302-B24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10654-006-0002-1","article-title":"Women\u2019s patterns of participation in mammography screening in Denmark","volume":"21","author":"von Euler-Chelpin","year":"2006","journal-title":"Eur J Epidemiol"},{"key":"2026110406524874000_djag302-B25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/ijc.20604","article-title":"Do nonattenders in mammography screening programmes seek mammography elsewhere?","volume":"113","author":"Jensen","year":"2005","journal-title":"Int J Cancer"},{"key":"2026110406524874000_djag302-B26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jms.9.3.115","article-title":"Early outcome of mammography screening in Copenhagen 1991-99","volume":"9","author":"Vejborg","year":"2002","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B27","author":"United Nations Population Division"},{"key":"2026110406524874000_djag302-B28","author":"Social Security"},{"key":"2026110406524874000_djag302-B29","author":"Office for National Statistics. Life Expectancy Calculator"},{"key":"2026110406524874000_djag302-B30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/aje\/kwy214","article-title":"Identification of the fraction of indolent tumors and associated overdiagnosis in breast cancer screening trials","volume":"188","author":"Ryser","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2026110406524874000_djag302-B31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0969141313495190","article-title":"Over-diagnosis estimate from the Independent UK Panel on Breast Cancer Screening is based on unsuitable data","volume":"20","author":"Njor","year":"2013","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/bmj.38764.572569.7C","article-title":"Rate of over-diagnosis of breast cancer 15 y\u00f6ears after end of Malm\u00f6 mammographic screening trial: follow-up study","volume":"332","author":"Zackrisson","year":"2006","journal-title":"BMJ"},{"key":"2026110406524874000_djag302-B33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1472-6874-9-36","article-title":"Overdiagnosis in organised mammography screening in Denmark. A comparative study","volume":"9","author":"Jorgensen","year":"2009","journal-title":"BMC Womens Health"},{"key":"2026110406524874000_djag302-B34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.7326\/M16-0270","article-title":"Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis","volume":"166","author":"Jorgensen","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026110406524874000_djag302-B35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejca.2017.04.018","article-title":"Overdiagnosis in breast cancer screening: the impact of study design and calculations","volume":"80","author":"Lynge","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026110406524874000_djag302-B36","doi-asserted-by":"publisher","first-page":"e046353","DOI":"10.1136\/bmjopen-2020-046353","article-title":"Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?","volume":"11","author":"Chaltiel","year":"2021","journal-title":"BMJ Open"},{"key":"2026110406524874000_djag302-B37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/bmjqs-2024-017709","article-title":"The problem with uptake as a quality metric for population-based screening programmes","volume":"34","author":"Armstrong","year":"2025","journal-title":"BMJ Qual Saf"},{"key":"2026110406524874000_djag302-B38","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/M15-0970","article-title":"Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"key":"2026110406524874000_djag302-B40","doi-asserted-by":"publisher","first-page":"CD001877","DOI":"10.1002\/14651858.CD001877.pub4","article-title":"Screening for breast cancer with mammography","volume":"1","author":"Gotzsche","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026110406524874000_djag302-B41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ijc.30758","article-title":"Benefit-to-harm ratio of the Danish breast cancer screening programme","volume":"141","author":"Beau","year":"2017","journal-title":"Int J Cancer"},{"key":"2026110406524874000_djag302-B42","doi-asserted-by":"publisher","first-page":"e016246","DOI":"10.1136\/bmjopen-2017-016246","article-title":"How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial","volume":"7","author":"Hersch","year":"2017","journal-title":"BMJ Open"},{"key":"2026110406524874000_djag302-B43","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/bjc.2014.482","article-title":"A survey study of women\u2019s responses to information about overdiagnosis in breast cancer screening in Britain","volume":"111","author":"Waller","year":"2014","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002703","article-title":"Women\u2019s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study","volume":"3","author":"Waller","year":"2013","journal-title":"BMJ Open"},{"key":"2026110406524874000_djag302-B45","author":"Kennedy"},{"key":"2026110406524874000_djag302-B46","author":"Demaree-Cotton","year":"2025"},{"key":"2026110406524874000_djag302-B47","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa052911","article-title":"Diagnostic performance of digital versus film mammography for breast-cancer screening","volume":"353","author":"Pisano","year":"2005","journal-title":"N Engl J Med"},{"key":"2026110406524874000_djag302-B48","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2214\/AJR.08.2157","article-title":"Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program","volume":"193","author":"Hambly","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"2026110406524874000_djag302-B49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0969141318814869","article-title":"Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands)","volume":"26","author":"Aarts","year":"2019","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jech.43.1.29","article-title":"Randomisation by cluster and the problem of social class bias","volume":"43","author":"Alexander","year":"1989","journal-title":"J Epidemiol Community Health"},{"key":"2026110406524874000_djag302-B51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/09691413211059461","article-title":"The randomized trial of mammography screening that was not\u2014A cautionary tale","volume":"29","author":"Yaffe","year":"2022","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B52","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9&lt;1017::AID-SIM508&gt;3.0.CO;2-V","article-title":"Adjusting for non-compliance and contamination in randomized clinical trials","volume":"16","author":"Cuzick","year":"1997","journal-title":"Statist Med"},{"key":"2026110406524874000_djag302-B53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7326\/M16-2586","article-title":"Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO Trials","volume":"167","author":"Tsodikov","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026110406524874000_djag302-B54","author":"Svendsen","year":"2024"},{"key":"2026110406524874000_djag302-B55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.critrevonc.2007.09.001","article-title":"Impact of aging on the biology of breast cancer","volume":"66","author":"Benz","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026110406524874000_djag302-B56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/bcr1314","article-title":"Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening","volume":"7","author":"Moss","year":"2005","journal-title":"Breast Cancer Res"},{"key":"2026110406524874000_djag302-B57","first-page":"349","article-title":"Ten- to fourteen-year effect of screening on breast cancer mortality","volume":"69","author":"Shapiro","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"2026110406524874000_djag302-B58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/bmj.297.6654.943","article-title":"Mammographic screening and mortality from breast cancer: the Malm\u00f6 mammographic screening trial","volume":"297","author":"Andersson","year":"1988","journal-title":"BMJ"},{"key":"2026110406524874000_djag302-B59","author":"Nelson","year":"2016"},{"key":"2026110406524874000_djag302-B60","first-page":"23","volume-title":"Cancer Screening","author":"Tabar","year":"1991"},{"key":"2026110406524874000_djag302-B61","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/s0959-8049(03)00259-4","article-title":"The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease","volume":"39","author":"Duffy","year":"2003","journal-title":"Eur J Cancer"},{"key":"2026110406524874000_djag302-B62","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/cncr.27580","article-title":"Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening","volume":"118","author":"Yen","year":"2012","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B63","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/bjc.1994.342","article-title":"The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up","volume":"70","author":"Alexander","year":"1994","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0749-3797(18)30734-7","article-title":"The costs and benefits of breast cancer screening","volume":"9","author":"Miller","year":"1993","journal-title":"Am J Prev Med"},{"key":"2026110406524874000_djag302-B65","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/0003-4819-137-5_part_1-200209030-00005","article-title":"The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years","volume":"137","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"2026110406524874000_djag302-B66","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/jnci\/92.18.1490","article-title":"Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years","volume":"92","author":"Miller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2026110406524874000_djag302-B67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF01975443","article-title":"Randomized study of mammography screening\u2014preliminary report on mortality in the Stockholm trial","volume":"18","author":"Frisell","year":"1991","journal-title":"Breast Cancer Res Treat"},{"key":"2026110406524874000_djag302-B68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/a:1005872617944","article-title":"Followup after 11 years\u2014update of mortality results in the Stockholm mammographic screening trial","volume":"45","author":"Frisell","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"2026110406524874000_djag302-B69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00665978","article-title":"Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance","volume":"35","author":"Lidbrink","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"2026110406524874000_djag302-B70","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#","article-title":"The Gothenburg Breast Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization","volume":"80","author":"Bjurstam","year":"1997","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/jncimono\/1997.22.53","article-title":"The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49","volume":"22","author":"Bjurstam","year":"1997","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2026110406524874000_djag302-B72","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/cncr.11361","article-title":"The Gothenburg Breast Screening Trial","volume":"97","author":"Bjurstam","year":"2003","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B73","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.bjc.6602396","article-title":"Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years","volume":"92","author":"Moss","year":"2005","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B74","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial","volume":"21","author":"Duffy","year":"2020","journal-title":"Lancet Oncol"},{"key":"2026110406524874000_djag302-B75","author":"G\u00f8tzsche"},{"key":"2026110406524874000_djag302-B76","author":"Frisell","year":"1989"},{"key":"2026110406524874000_djag302-B77","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/1097-0142(196712)20:12&lt;2184::AID-CNCR2820201217&gt;3.0.CO;2-3","article-title":"Mammography and clinical examination in mass screening for cancer of the breast","volume":"20","author":"Strax","year":"1967","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B78","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/1097-0142(196904)23:4<875::AID-CNCR2820230422>3.0.CO;2-0","article-title":"Mass screening in mammary cancer","volume":"23","author":"Strax","year":"1969","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B79","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jama.1966.03100090065016","article-title":"Evaluation of periodic breast cancer screening with mammography. Methodology and early observations","volume":"195","author":"Shapiro","year":"1966","journal-title":"JAMA"},{"key":"2026110406524874000_djag302-B80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ijc.2910460211","article-title":"A model-based analysis of the HIP project for breast cancer screening","volume":"46","author":"van Oortmarssen","year":"1990","journal-title":"Int J Cancer"},{"key":"2026110406524874000_djag302-B81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0091-7435(73)90070-4","article-title":"Evaluation of two contrasting types of screening programs","volume":"2","author":"Shapiro","year":"1973","journal-title":"Prev Med"},{"key":"2026110406524874000_djag302-B82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/978-3-642-82031-1_15","article-title":"Breast cancer screening in Malm\u00f6","volume":"90","author":"Andersson","year":"1984","journal-title":"Recent Results Cancer Res"},{"key":"2026110406524874000_djag302-B83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-5122(85)90031-3","article-title":"Mammographic breast cancer screening\u2014a randomized trial in Malm\u00f6, Sweden","volume":"7","author":"Andersson","year":"1985","journal-title":"Maturitas"},{"key":"2026110406524874000_djag302-B84","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(85)92204-4","article-title":"Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare","volume":"1","author":"Tabar","year":"1985","journal-title":"Lancet"},{"key":"2026110406524874000_djag302-B85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0033-8389(22)02494-0","article-title":"Update of the Swedish Two-County program of mammographic screening for breast cancer","volume":"30","author":"Tabar","year":"1992","journal-title":"Radiol Clin North Am"},{"key":"2026110406524874000_djag302-B86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1258\/jms.2009.009094","article-title":"Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England","volume":"17","author":"Duffy","year":"2010","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1984.132","article-title":"The Edinburgh randomised trial of screening for breast cancer: description of method","volume":"50","author":"Roberts","year":"1984","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B88","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1054\/bjoc.2000.1286","article-title":"Pathology characteristics that optimize outcome prediction of a breast screening trial","volume":"83","author":"Anderson","year":"2000","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B89","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0140-6736(90)90066-e","article-title":"Edinburgh trial of screening for breast cancer: mortality at seven years","volume":"335","author":"Roberts","year":"1990","journal-title":"Lancet"},{"key":"2026110406524874000_djag302-B90","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/s0140-6736(98)07413-3","article-title":"14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening","volume":"353","author":"Alexander","year":"1999","journal-title":"Lancet"},{"key":"2026110406524874000_djag302-B91","first-page":"227","article-title":"The National Study of Breast Cancer Screening Protocol for a Canadian randomized controlled trial of screening for breast cancer in women","volume":"4","author":"Miller","year":"1981","journal-title":"Clin Invest Med"},{"key":"2026110406524874000_djag302-B92","first-page":"1459","article-title":"Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years","volume":"147","author":"Miller","year":"1992","journal-title":"CMAJ"},{"key":"2026110406524874000_djag302-B93","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/s0749-3797(98)00074-9","article-title":"Assessing the extent of contamination in the Canadian National Breast Screening Study","volume":"15","author":"Goel","year":"1998","journal-title":"Am J Prev Med"},{"key":"2026110406524874000_djag302-B94","doi-asserted-by":"publisher","first-page":"g366","DOI":"10.1136\/bmj.g366","article-title":"Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial","volume":"348","author":"Miller","year":"2014","journal-title":"BMJ"},{"key":"2026110406524874000_djag302-B95","first-page":"1477","article-title":"Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years","volume":"147","author":"Miller","year":"1992","journal-title":"CMAJ"},{"key":"2026110406524874000_djag302-B96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF01805924","article-title":"Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons","volume":"8","author":"Frisell","year":"1986","journal-title":"Breast Cancer Res Treat"},{"key":"2026110406524874000_djag302-B97","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF01806383","article-title":"Analysis of interval breast carcinomas in a randomized screening trial in Stockholm","volume":"9","author":"Frisell","year":"1987","journal-title":"Breast Cancer Res Treat"},{"key":"2026110406524874000_djag302-B98","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF01806553","article-title":"The Stockholm breast cancer screening trial\u20145-year results and stage at discovery","volume":"13","author":"Frisell","year":"1989","journal-title":"Breast Cancer Res Treat"},{"key":"2026110406524874000_djag302-B99","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0140-6736(93)91067-v","article-title":"Breast cancer screening with mammography: overview of Swedish randomised trials","volume":"341","author":"Nystrom","year":"1993","journal-title":"Lancet"},{"key":"2026110406524874000_djag302-B100","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/jms.6.3.144","article-title":"A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group","volume":"6","author":"Moss","year":"1999","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B101","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years\u2019 follow-up: a randomised controlled trial","volume":"16","author":"Moss","year":"2015","journal-title":"Lancet Oncol"},{"key":"2026110406524874000_djag302-B102","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1158\/1055-9965.EPI-09-0996","article-title":"Assessing the amount of unscheduled screening (\u201ccontamination\u201d) in the control arm of the UK \u201cAge\u201d Trial","volume":"19","author":"Kingston","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026110406524874000_djag302-B103","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a115813","article-title":"Analysis of the temporal patterns of benefits in the Health Insurance Plan of Greater New York trial by stage and age","volume":"133","author":"Chu","year":"1991","journal-title":"Am J Epidemiol"},{"key":"2026110406524874000_djag302-B104","first-page":"65","article-title":"Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening","volume":"67","author":"Shapiro","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"2026110406524874000_djag302-B105","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(06)69834-6","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years\u2019 follow-up: a randomised controlled trial","volume":"368","author":"Moss","year":"2006","journal-title":"Lancet"},{"key":"2026110406524874000_djag302-B106","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/oxfordjournals.aje.a112046","article-title":"Lead time in breast cancer detection and implications for periodicity of screening","volume":"100","author":"Shapiro","year":"1974","journal-title":"Am J Epidemiol"},{"key":"2026110406524874000_djag302-B107","first-page":"665","article-title":"Lead time gained by diagnostic screening for breast cancer","volume":"41","author":"Hutchison","year":"1968","journal-title":"J Natl Cancer Inst"},{"key":"2026110406524874000_djag302-B108","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/1097-0142(197706)39:6&lt;2772::AID-CNCR2820390665&gt;3.0.CO;2-K","article-title":"Evidence on screening for breast cancer from a randomized trial","volume":"39","author":"Shapiro","year":"1977","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B109","first-page":"133","volume-title":"Screening in Cancer: A Report of a UICC International Workshop, Toronto, Canada.","author":"Shapiro","year":"1978"},{"key":"2026110406524874000_djag302-B110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/sim.4780010104","article-title":"Effect of different mammographic radiation exposures on predicted benefits of screening for breast cancer","volume":"1","author":"Dubin","year":"1982","journal-title":"Stat Med"},{"key":"2026110406524874000_djag302-B111","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2105\/ajph.72.10.1142","article-title":"Prospects for eliminating racial differences in breast cancer survival rates","volume":"72","author":"Shapiro","year":"1982","journal-title":"Am J Public Health"},{"key":"2026110406524874000_djag302-B112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01671148","article-title":"The status of breast cancer screening: a quarter of a century of research","volume":"13","author":"Shapiro","year":"1989","journal-title":"World J Surg"},{"key":"2026110406524874000_djag302-B113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jncimono\/1997.22.27","article-title":"Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan","volume":"22","author":"Shapiro","year":"1997","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2026110406524874000_djag302-B114","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jnci\/dji239","article-title":"Role of detection method in predicting breast cancer survival: analysis of randomized screening trials","volume":"97","author":"Shen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2026110406524874000_djag302-B115","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/jnci\/80.14.1125","article-title":"Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial","volume":"80","author":"Chu","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"2026110406524874000_djag302-B116","author":"Andersson","year":"1989:"},{"key":"2026110406524874000_djag302-B117","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/02841868509134418","article-title":"Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county","volume":"24","author":"Fagerberg","year":"1985","journal-title":"Acta Radiol Oncol"},{"key":"2026110406524874000_djag302-B118","first-page":"158","article-title":"Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden","volume":"54","author":"Tabar","year":"1985","journal-title":"Diagn Imaging Clin Med"},{"key":"2026110406524874000_djag302-B119","first-page":"33","volume-title":"Screening for Breast Cancer.","author":"Fagerberg","year":"1988"},{"key":"2026110406524874000_djag302-B120","first-page":"39","volume-title":"Screening for Breast Cancer.","author":"Tabar","year":"1988"},{"key":"2026110406524874000_djag302-B121","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.1991.477","article-title":"Breast screening, prognostic factors and survival\u2014results from the Swedish Two County study","volume":"64","author":"Duffy","year":"1991","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B122","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/1097-0142(19930815)72:4+&lt;1437::AID-CNCR2820721405&gt;3.0.CO;2-M","article-title":"New Swedish breast cancer detection results for women aged 40-49","volume":"72","author":"Tabar","year":"1993","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B123","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/096914139500200208","article-title":"Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology","volume":"2","author":"Tabar","year":"1995","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B124","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z","article-title":"Tumour development, histology and grade of breast cancers: prognosis and progression","volume":"66","author":"Tabar","year":"1996","journal-title":"Int J Cancer"},{"key":"2026110406524874000_djag302-B125","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/s0033-8389(05)70191-3","article-title":"The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up","volume":"38","author":"Tabar","year":"2000","journal-title":"Radiol Clin North Am"},{"key":"2026110406524874000_djag302-B126","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1046\/j.0007-1323.2001.01902.x","article-title":"Estimating the benefits of adjuvant systemic therapy for women with early breast cancer","volume":"88","author":"Grogan","year":"2001","journal-title":"Br J Surg"},{"key":"2026110406524874000_djag302-B127","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jms.9.4.159","article-title":"All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point","volume":"9","author":"Tabar","year":"2002","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B128","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/s0959-8049(03)00260-0","article-title":"Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening","volume":"39","author":"Yen","year":"2003","journal-title":"Eur J Cancer"},{"key":"2026110406524874000_djag302-B129","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/annonc\/mdg322","article-title":"The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation","volume":"14","author":"Duffy","year":"2003","journal-title":"Ann Oncol"},{"key":"2026110406524874000_djag302-B130","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/cncr.20140","article-title":"Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study","volume":"100","author":"Warwick","year":"2004","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B131","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1177\/0969141306013001S08","article-title":"Some issues in screening for breast and other cancers","volume":"13 Suppl 1","author":"Duffy","year":"2006","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B132","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1258\/jms.2009.008103","article-title":"Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences","volume":"16","author":"Holmberg","year":"2009","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B133","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.11110469","article-title":"Swedish Two-County Trial: impact of mammographic screening on breast cancer mortality during 3 decades","volume":"260","author":"Tabar","year":"2011","journal-title":"Radiology"},{"key":"2026110406524874000_djag302-B134","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/1055-9965.EPI-17-0487","article-title":"Effect of mammography screening on mortality by histological grade","volume":"27","author":"Tabar","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026110406524874000_djag302-B135","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/096914139500200104","article-title":"Effect of breast cancer screening after age 65","volume":"2","author":"Chen","year":"1995","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B136","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/0272989X16660711","article-title":"Using simulation to model and validate invasive breast cancer progression in women in the study and control groups of the Canadian National Breast Screening Studies I and II","volume":"37","author":"Taghipour","year":"2017","journal-title":"Med Decis Making"},{"key":"2026110406524874000_djag302-B137","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4103\/0973-1482.174539","article-title":"Tumor size distribution of invasive breast cancers and the sensitivity of screening methods in the Canadian National Breast Screening Study","volume":"13","author":"Shaevitch","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"2026110406524874000_djag302-B138","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.20143","article-title":"Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation","volume":"110","author":"Rijnsburger","year":"2004","journal-title":"Int J Cancer"},{"key":"2026110406524874000_djag302-B139","doi-asserted-by":"publisher","first-page":"e1008036","DOI":"10.1371\/journal.pcbi.1008036","article-title":"Is mammography screening beneficial: an individual-based stochastic model for breast cancer incidence and mortality","volume":"16","author":"Le","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"2026110406524874000_djag302-B140","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jncimono\/1997.22.49","article-title":"The Stockholm Mammographic Screening Trial: risks and benefits in age group 40-49 years","volume":"22","author":"Frisell","year":"1997","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2026110406524874000_djag302-B141","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/cncr.29975","article-title":"Updated results of the Gothenburg Trial of Mammographic Screening","volume":"122","author":"Bjurstam","year":"2016","journal-title":"Cancer"},{"key":"2026110406524874000_djag302-B142","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.humpath.2004.07.011","article-title":"Influence of annual mammography from age 40 on breast cancer pathology","volume":"35","author":"Anderson","year":"2004","journal-title":"Hum Pathol"},{"key":"2026110406524874000_djag302-B143","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/sj.bjc.6602395","article-title":"Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures","volume":"92","author":"Moss","year":"2005","journal-title":"Br J Cancer"},{"key":"2026110406524874000_djag302-B144","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0969141316648987","article-title":"Reduced breast cancer mortality after 20+ years of follow-up in \u00f6the Swedish randomized controlled mammography trials in Malm\u00f6, Stockholm, and Goteborg","volume":"24","author":"Nystrom","year":"2017","journal-title":"J Med Screen"},{"key":"2026110406524874000_djag302-B145","first-page":"45","volume-title":"Cancer Screening","author":"Miller","year":"1991"},{"key":"2026110406524874000_djag302-B146","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/1097-0142(19891215)64:2+&lt;2641::AID-CNCR2820641403&gt;3.0.CO;2-Y","article-title":"The Health Insurance Plan of New York Study. Clinical aspects","volume":"64","author":"Strax","year":"1989","journal-title":"Cancer."},{"key":"2026110406524874000_djag302-B147","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1080\/110241500447227","article-title":"Survival of women with breast cancer in relation to smoking","volume":"166","author":"Manjer","year":"2000","journal-title":"Eur J Surg"},{"key":"2026110406524874000_djag302-B148","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/sim.4780080611","article-title":"Estimation of sojourn time distributions and false negative rates in screening programmes which use two modalities","volume":"8","author":"Alexander","year":"1989","journal-title":"Stat Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag302\/71046283\/djag302.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag302\/71046283\/djag302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:52:58Z","timestamp":1793793178000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article\/doi\/10.1093\/jnci\/djag302\/8792903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":148,"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag302","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"djag302"}}